Cargando…
Sputum Biomarkers and the Prediction of Clinical Outcomes in Patients with Cystic Fibrosis
Lung function, acute pulmonary exacerbations (APE), and weight are the best clinical predictors of survival in cystic fibrosis (CF); however, underlying mechanisms are incompletely understood. Biomarkers of current disease state predictive of future outcomes might identify mechanisms and provide tre...
Autores principales: | Liou, Theodore G., Adler, Frederick R., Keogh, Ruth H., Li, Yanping, Jensen, Judy L., Walsh, William, Packer, Kristyn, Clark, Teresa, Carveth, Holly, Chen, Jun, Rogers, Shaunessy L., Lane, Christen, Moore, James, Sturrock, Anne, Paine, Robert, Cox, David R., Hoidal, John R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416785/ https://www.ncbi.nlm.nih.gov/pubmed/22916155 http://dx.doi.org/10.1371/journal.pone.0042748 |
Ejemplares similares
-
Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis
por: Liou, Theodore G., et al.
Publicado: (2019) -
Evaluation of a five-year predicted survival model for cystic fibrosis in later time periods
por: Liou, Theodore G., et al.
Publicado: (2020) -
Refinement of metabolite detection in cystic fibrosis sputum reveals heme correlates with lung function decline
por: Glasser, Nathaniel R., et al.
Publicado: (2019) -
The Dynamics of Disease Progression in Cystic Fibrosis
por: Adler, Frederick R., et al.
Publicado: (2016) -
Azithromycin and the microbiota of cystic fibrosis sputum
por: Acosta, Nicole, et al.
Publicado: (2021)